These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38888299)

  • 21. Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody-Maytansinoid Conjugates.
    Ponte JF; Sun X; Yoder NC; Fishkin N; Laleau R; Coccia J; Lanieri L; Bogalhas M; Wang L; Wilhelm S; Widdison W; Pinkas J; Keating TA; Chari R; Erickson HK; Lambert JM
    Bioconjug Chem; 2016 Jul; 27(7):1588-98. PubMed ID: 27174129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual intra- and extracellular release of monomethyl auristatin E from a neutrophil elastase-sensitive antibody-drug conjugate.
    Mohamed Amar IA; Huvelle S; Douez E; Letast S; Henrion S; Viaud-Massuard MC; Aubrey N; Allard-Vannier E; Joubert N; Denevault-Sabourin C
    Eur J Med Chem; 2022 Feb; 229():114063. PubMed ID: 34974337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploration of Pyrrolobenzodiazepine (PBD)-Dimers Containing Disulfide-Based Prodrugs as Payloads for Antibody-Drug Conjugates.
    Pei Z; Chen C; Chen J; Cruz-Chuh JD; Delarosa R; Deng Y; Fourie-O'Donohue A; Figueroa I; Guo J; Jin W; Khojasteh SC; Kozak KR; Latifi B; Lee J; Li G; Lin E; Liu L; Lu J; Martin S; Ng C; Nguyen T; Ohri R; Lewis Phillips G; Pillow TH; Rowntree RK; Stagg NJ; Stokoe D; Ulufatu S; Verma VA; Wai J; Wang J; Xu K; Xu Z; Yao H; Yu SF; Zhang D; Dragovich PS
    Mol Pharm; 2018 Sep; 15(9):3979-3996. PubMed ID: 30040421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cathepsin B Is Dispensable for Cellular Processing of Cathepsin B-Cleavable Antibody-Drug Conjugates.
    Caculitan NG; Dela Cruz Chuh J; Ma Y; Zhang D; Kozak KR; Liu Y; Pillow TH; Sadowsky J; Cheung TK; Phung Q; Haley B; Lee BC; Akita RW; Sliwkowski MX; Polson AG
    Cancer Res; 2017 Dec; 77(24):7027-7037. PubMed ID: 29046337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, Synthesis, and Biological Evaluation of Water-Soluble Prodrugs of C5-Curcuminoid GO-Y030 Based on Reversible Thia-Michael Reaction.
    Yamakoshi H; Fukuda M; Ikeda H; Fujiki S; Kohyama A; Nagasawa S; Shinozaki H; Shibata H; Iwabuchi Y
    Chem Pharm Bull (Tokyo); 2024; 72(1):127-134. PubMed ID: 38296515
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Lee VEY; Lim ZC; Chew SL; Ang WH
    Inorg Chem; 2021 Feb; 60(3):1823-1831. PubMed ID: 33464875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ROS-responsive "smart" polymeric conjugate: Synthesis, characterization and proof-of-concept study.
    Oddone N; Pederzoli F; Duskey JT; De Benedictis CA; Grabrucker AM; Forni F; Angela Vandelli M; Ruozi B; Tosi G
    Int J Pharm; 2019 Oct; 570():118655. PubMed ID: 31479731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody Drug Conjugates for Cancer Therapy.
    Polakis P
    Pharmacol Rev; 2016 Jan; 68(1):3-19. PubMed ID: 26589413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates.
    Acchione M; Kwon H; Jochheim CM; Atkins WM
    MAbs; 2012; 4(3):362-72. PubMed ID: 22531451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineering Enzyme-Cleavable Oligonucleotides by Automated Solid-Phase Incorporation of Cathepsin B Sensitive Dipeptide Linkers.
    Jin C; Ei-Sagheer AH; Li S; Vallis KA; Tan W; Brown T
    Angew Chem Int Ed Engl; 2022 Mar; 61(13):e202114016. PubMed ID: 34953094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversibility of the thia-Michael reaction of cytotoxic C
    Kohyama A; Fukuda M; Sugiyama S; Yamakoshi H; Kanoh N; Ishioka C; Shibata H; Iwabuchi Y
    Org Biomol Chem; 2016 Dec; 14(45):10683-10687. PubMed ID: 27801454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of a Thiol-Responsive, Traceless Prodrug with Rapid Self-Immolation for Cancer Chemotherapy.
    Liu G; Jiang Z; Lovell JF; Zhang L; Zhang Y
    ACS Appl Bio Mater; 2021 Jun; 4(6):4982-4989. PubMed ID: 35007046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of ketone-oxime method for developing therapeutic on-demand cleavable immunoconjugates.
    Kumaresan PR; Luo J; Song A; Marik J; Lam KS
    Bioconjug Chem; 2008 Jun; 19(6):1313-8. PubMed ID: 18494516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toward a Ferrous Iron-Cleavable Linker for Antibody-Drug Conjugates.
    Spangler B; Kline T; Hanson J; Li X; Zhou S; Wells JA; Sato AK; Renslo AR
    Mol Pharm; 2018 May; 15(5):2054-2059. PubMed ID: 29569925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linkers Having a Crucial Role in Antibody-Drug Conjugates.
    Lu J; Jiang F; Lu A; Zhang G
    Int J Mol Sci; 2016 Apr; 17(4):561. PubMed ID: 27089329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Chemical Design and Synthesis of Linkers Used in Antibody Drug Conjugates.
    Frigerio M; Kyle AF
    Curr Top Med Chem; 2017; 17(32):3393-3424. PubMed ID: 29357801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions.
    Jackson PA; Widen JC; Harki DA; Brummond KM
    J Med Chem; 2017 Feb; 60(3):839-885. PubMed ID: 27996267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linker.
    Liubomirski Y; Tiram G; Scomparin A; Gnaim S; Das S; Gholap S; Ge L; Yeini E; Shelef O; Zauberman A; Berger N; Kalimi D; Toister-Achituv M; Schröter C; Dickgiesser S; Tonillo J; Shan M; Deutsch C; Sweeney-Lasch S; Shabat D; Satchi-Fainaro R
    J Control Release; 2024 Mar; 367():148-157. PubMed ID: 38228272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-Immolative Linkers Literally Bridge Disulfide Chemistry and the Realm of Thiol-Free Drugs.
    Riber CF; Smith AA; Zelikin AN
    Adv Healthc Mater; 2015 Aug; 4(12):1887-90. PubMed ID: 26109168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving the Stability of Maleimide-Thiol Conjugation for Drug Targeting.
    Lahnsteiner M; Kastner A; Mayr J; Roller A; Keppler BK; Kowol CR
    Chemistry; 2020 Dec; 26(68):15867-15870. PubMed ID: 32871016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.